|
|
|
|
Clinical Trials
- X-3 Polyethylene Outcomes Study
ClinicalTrials.gov Identifier: NCT00493792 - Recruiting
Arthroplasty, Replacement, Knee; Total Knee Replacement
- X-Change HF - Exchange of the Existing Pacemaker / ICD in Bradicardia Patients Suffering from Heart Failure
ClinicalTrials.gov Identifier: NCT00157846 - Recruiting
Bradycardia; Heart Failure; LVEF < 35%
- X-Chromosome Inactivation Status and Premature Ovarian Failure
ClinicalTrials.gov Identifier: NCT00295087 - Recruiting
Premature Ovarian Failure
- Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension
ClinicalTrials.gov Identifier: NCT00219596 - Completed
Glaucoma, Open Angle; Ocular Hypertension
- Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients
ClinicalTrials.gov Identifier: NCT00081783 - Recruiting
Non-Hodgkin's Lymphoma
- Xcellerated T CellsTM in Patients with Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00078065 - Completed
Multiple Myeloma
- Xeloda Vs Monitoring in Advanced Colorectal Cancer Responsive to Chemotherapy
ClinicalTrials.gov Identifier: NCT00189683 - Recruiting
Colorectal Cancer
- Xeloda vs. TS-1 as First-Line Treatment in Unresectable or Recurrent Breast Cancer
ClinicalTrials.gov Identifier: NCT00438100 - Not yet recruiting
Breast Neoplasms
- Xelox Avastin for Metastatic Esophagogastric Adenocarcinoma
ClinicalTrials.gov Identifier: NCT00447330 - Recruiting
Esophageal Neoplasms; Stomach Neoplasms; Neoplasm Metastasis
- XELOX for Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00204776 - Completed
Metastatic Breast Cancer
- XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00212615 - Active, not recruiting
C04.588.274.476.411.307
- XELOX Plus Cetuximab as First-Line Therapy in Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00215722 - Active, not recruiting
Colorectal Carcinoma
- XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma
ClinicalTrials.gov Identifier: NCT00557713 - Recruiting
Rectal Neoplasms; Locally Advanced Rectal Adenocarcinoma
- Xenogeneic HER2/Neu DNA Immunization for Patients With Metastatic and High Risk Breast Cancer: A Phase I Study to Assess Safety and Immunogenicity
ClinicalTrials.gov Identifier: NCT00393783 - Recruiting
Breast Cancer
- Xenon Inhalation During Orthopaedic Surgery in Elderly Subjects.
ClinicalTrials.gov Identifier: NCT00192959 - Completed
Anaesthesia; Postoperative Cognitive Function
- XENOX – Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy
ClinicalTrials.gov Identifier: NCT00272051 - Completed
Metastases; Colorectal Neoplasms; Colorectal Carcinoma
- Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure
ClinicalTrials.gov Identifier: NCT00168116 - Active, not recruiting
Head and Neck Cancer
- XIENCE™ SPIRIT Women Clinical Evaluation of the XIENCE™ V Everolimus Eluting Coronary Stent System (EECCS)
ClinicalTrials.gov Identifier: NCT00496938 - Not yet recruiting
Coronary Arteriosclerosis; Coronary Artery Disease; Coronary Restenosis
- XK469 in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00028548 - Completed
unspecified adult solid tumor, protocol specific
- XK469 in Treating Patients With Advanced Solid Tumors or Lymphoma
ClinicalTrials.gov Identifier: NCT00028522 - Recruiting
adult solid tumor; Leukemia; Lymphoma; small intestine cancer
- XK469R in Treating Patients With Refractory Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00095797 - Completed
acute leukemia; adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; chronic leukemia
- XL119 Versus 5-Fluorouracil (5-FU) plus Leucovorin (LV) in Subjects with Advanced Biliary Tumors
ClinicalTrials.gov Identifier: NCT00090025 - Terminated
Biliary Tract Cancer
- Xolair in Patients with Chronic Sinusitis
ClinicalTrials.gov Identifier: NCT00117611 - Recruiting
Sinusitis
- XP13512 Extension Study in Patients With Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00333359 - Recruiting
Restless Legs Syndrome
- XP13512 Versus Placebo in Patients With Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00298623 - Completed
Restless Legs Syndrome
- XP13512 vs. Placebo in Patients With Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00365352 - Active, not recruiting
Restless Legs Syndrome
- Xray Volume Imaging (Cone Beam CT) - Prostate Cancer
ClinicalTrials.gov Identifier: NCT00188799 - Completed
Prostatic Neoplasms
- XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer (TROPIC)
ClinicalTrials.gov Identifier: NCT00417079 - Recruiting
Neoplasms; Prostatic Neoplasms
- XRP9881 in Combination With Trastuzumab in Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00386685 - Recruiting
Breast Neoplasms
- XRP9881 or Capecitabine in Treating Patients With Recurrent Inoperable or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00107406 - Recruiting
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- Xtract™ Aspiration Catheter Registry Study
ClinicalTrials.gov Identifier: NCT00349570 - Recruiting
Fresh Soft Emboli or Thrombi in the Arteries.
- Xylitol Adult Caries Trial (X-ACT)
ClinicalTrials.gov Identifier: NCT00393055 - Recruiting
Dental Caries
- Xyrem for Treatment Refractory Insomnia Due to PTSD
ClinicalTrials.gov Identifier: NCT00330291 - Terminated
PTSD; Anxiety, Post Traumatic
- Xyrem(Sodium Oxybate) and Ambien(Zolpidem Tartrate) in the Treatment of Chronic Insomnia.
ClinicalTrials.gov Identifier: NCT00383643 - Recruiting
Chronic Insomnia

Not Signed In -


